CVE-2023-20123

Cisco Duo Authentication for macOS and Duo Authentication for Windows Logon Offline Credentials Replay Vulnerability

Description

A vulnerability in the offline access mode of Cisco Duo Two-Factor Authentication for macOS and Duo Authentication for Windows Logon and RDP could allow an unauthenticated, physical attacker to replay valid user session credentials and gain unauthorized access to an affected macOS or Windows device. This vulnerability exists because session credentials do not properly expire. An attacker could exploit this vulnerability by replaying previously used multifactor authentication (MFA) codes to bypass MFA protection. A successful exploit could allow the attacker to gain unauthorized access to the affected device.

Category

6.3
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.02%
Vendor Advisory cisco.com
Affected: Cisco Cisco Duo
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-20123?
CVE-2023-20123 has been scored as a medium severity vulnerability.
How to fix CVE-2023-20123?
To fix CVE-2023-20123, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-20123 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-20123 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-20123?
CVE-2023-20123 affects Cisco Cisco Duo .
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.